Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Li Tai
Observed names:
L Tai,
Tai, Li
Institution:
Ionis Pharmaceuticals (United States)
Observed institution:
Ionis Pharmaceuticals (United States)
OpenAlex ID:
A5113849200
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial
2018
·
Marcia Waddington-Cruz
, Elizabeth J. Ackermann
, et al.
·
Amyloid
·
26
PDF
Evaluation of the Efficacy and Safety of Ionis-ttr-lrx in Patients With Transthyretin-mediated Amyloid Cardiomyopathy: the Cardio-ttransform Study
2021
·
M Maurer
, A Kristen
, et al.
·
Canadian Journal of Cardiology
·
6
Inotersen Improves Quality of Life in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy and Cardiomyopathy: Results of the Phase 3 Study Neuro-ttr
2018
·
Mathew S. Maurer
, Stephen Heitner
, et al.
·
Journal of the American College of Cardiology
·
6
PDF
P010. Evaluation of the Efficacy and Safety of AKCEA-TTR-LRx (ION-682884) in Patients with Transthyretin-mediated Amyloid Cardiomyopathy: The CARDIO-TTRansform Study
2021
·
Mathew Maurer
, Merrill Benson
, et al.
·
Heart & Lung
·
4
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial
2018
·
Waddington-Cruz, Marcia
, Ackermann, Elizabeth J.
, et al.
·
Figshare
Show more works
View as search
Works count:
5
Citation count:
42
H-index:
4
I10-index:
1
Year
Topic
Type